Long-term changes of aortic 18F-FDG uptake and calcification in health-screening subjects

Annals of Nuclear Medicine

Volumn 27, Issue 3, 2013, Pages 239-246

  Ryu, Yoshiharu ^a   Yoshida, Katsuya ^b   Suzuki, Yoshifumi ^b   Nakadate, Masashi ^a   Umehara, Isao ^b   Tomita, Makoto ^a   Shibuya, Hitoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Positron emission tomography; Risk factors; Vascular calcification; Vascular inflammation

Indexed keywords

CALCIUM; FLUORODEOXYGLUCOSE F 18;

ABDOMINAL AORTA; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CALCIFICATION; CARDIOVASCULAR INFLAMMATION; DESCENDING AORTA; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SMOKING HABIT; THORACIC AORTA;

ADULT; AGED; AORTA; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CALCINOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEALTH; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84880698347     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-012-0679-z     Document Type: Article

References (26)

1. Chen W, Bural GG, Torigian DA, Rader DJ, Alavi A. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2009;36:144-51.
2. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol. 2010;55:2527-35.
3. Agatston A, Janowitz W, Hildner F, Zusmer N, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827-32.
4. Menezes LJ, Kotze CW, Hutton BF, Endozo R, Dickson JC, Cullum I, et al. Vascular inflammation imaging with 18F-FDG PET/CT: when to image? J Nucl Med. 2009;50:854-7.
5. 18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). J Vis Exp. 2012;63:e3777.
6. Nakagawa K, Namba H, Iyo M, Fukushi K, Irie T, Yamanouchi M, et al. Simplified PET quantitation of myocardial glucose. J Nucl Med. 1995;36:2094-102.
7. Yoshida K, Endo M, Fukuda H, Kagaya A, Himi T, Masuda Y, et al. Measurement of arterial tracer concentrations from cardiac PET images. J Comput Assist Tomogr. 1995;19:182-7.
8. Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195(2):310-20.
9. 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque. Atherosclerosis. 2010;211(1):136-40.
10. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113-32.
11. Jayalath RW, Mangan SH, Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg. 2005;30:476-88.
12. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009;2:107-15.
13. 18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007;49:1533-9.
14. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging. 2008;35:319-28.
15. Ministry of Health, Labour and Welfare of Japan. NIPPON DATA (National Integrated Project for Prospective Observation of Non-communicable Disease And its Trends in the Age performed in Nov., 2010) http://www.mhlw.go.jp/toukei/ saikin/hw/kenkou/jyunkan/jyunkan00/gaiyo.html (in Japanese). Accessed 21 Mar 2012.
16. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229:831-7.
17. 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46:1278-84.
18. Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation. 2005;111:816-28.
19. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis. 1985;5:293-302.
20. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995;75:519-60.
21. Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2009;29(10):1458-64.
22. Public Relations Office, Government of Japan. Taking Stock of the Ningen Dock, Highlighting Japan 2010. http://www.gov-online.go.jp/eng/publicity/book/ hlj/html/201006/201006-04.html (in English). Accessed 7 Aug 2012.
23. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-31.
24. Wu YW, Kao HL, Huang CL, Chen MF, Lin LY, Wang YC, et al. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Eur J Nucl Med Mol Imaging. 2012;39(3):399-407.
25. Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, et al. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging. 2011;4(10):1110-8.
26. 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. J Nucl Med. 2008;49:1277-82.